John Lewis said,"If not us, then who? If not now, then when?
We may not have chosen the time, but the time has chosen us."

Frankly, we are DONE with the disparities in breast cancer care that cost Black women their lives! Join us in our movement to change the world!

The mortality statistics for Black women are horrificfor every 100 white women who die of breast cancer, 141 Black women die.

Black women are drastically underrepresented in clinical trials. Only 3% of clinical trial participants leading to FDA approval of cancer drugs between 2008 and 2018 were Black. The consequences are diretoo many Black women are missing out on access to newly emerging and often life-extending treatments. Until more Black women are included in research, we will continue to face worse breast cancer outcomes. 

Tomorrow, Wednesday, January 26th,
we are launching our
When We Tri(al) Movement!

This is a call to action for our fierce, resilient community of Black women. As Black breast cancer patients, we have to advocate for ourselves and each other in order to get access to a better Black standard of care.This is a matter of life and death for Black women. 

We MUST address the real impact of earned mistrust in medical research and associated fears.

We MUST educate on the fundamentals and benefits of clinical research and dispel the myths.

We MUST demand the care that we deserve.

We MUST do this for our daughters, our granddaughters and our community.

It’s up to us, together!

Our participation in clinical trials will change the game on advancing the science for all Black women diagnosed with breast cancer. 

Learn more at our When We Tri(al) Launch Event Page.

The Doctor Is In
Wednesday, January 26th, 6pm EST
This unprecedented initiative is made possible by the generous support of our partners: Genentech, a member of the Roche Group, Bristol Myers Squibb, AstraZeneca, Novartis, Pfizer, Seagen, Daiichi-Sankyo, and Eisai.

Please visit to learn more. 
TOUCH, The Black Breast Cancer Alliance